New patent for Gilead Sciences drug EPCLUSA

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for EPCLUSA
Annual Drug Patent Expirations for EPCLUSA

Epclusa is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from one supplier. There are twenty-six patents protecting this drug.

EPCLUSA drug price trends.

Drug patent litigation for EPCLUSA.

This drug has four hundred and twenty-two patent family members in forty-seven countries.

The generic ingredient in EPCLUSA is sofosbuvir; velpatasvir. One supplier is listed for this compound. Additional details are available on the sofosbuvir; velpatasvir profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top